Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_assertion type Assertion NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_head.
- NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_assertion description "[Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_provenance.
- NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_assertion evidence source_evidence_literature NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_provenance.
- NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_assertion SIO_000772 20065949 NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_provenance.
- NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_assertion wasDerivedFrom befree-20150227 NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_provenance.
- NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_assertion wasGeneratedBy ECO_0000203 NP965427.RAMUbmyGxw6n1S5JJdWWGUYgv6dRMru4nNECr54uPYyOU130_provenance.